Pruban
resocortol butyrate
Table of contents
Withdrawn
This medicine is now withdrawn from use in the European Union.
Overview
The marketing authorisation for Pruban has not been renewed by the marketing authorisation holder and is now withdrawn.
This EPAR was last updated on 26/07/2010
Authorisation details
| Product details | |
|---|---|
| Name |
Pruban
|
| Agency product number |
EMEA/V/C/000048
|
| Active substance |
resocortol butyrate
|
| International non-proprietary name (INN) or common name |
resocortol butyrate
|
| Species |
Dogs
|
| Anatomical therapeutic chemical veterinary (ATCvet) codes |
QD07AC90
|
| Publication details | |
|---|---|
| Marketing-authorisation holder |
Intervet International BV
|
| Revision |
4
|
| Date of issue of marketing authorisation valid throughout the European Union |
16/11/2000
|
| Contact address |
Intervet International B.V.
Wim de Körverstraat 35 5831 AN Boxmeer The Netherlands |
Product information
14/06/2010 Pruban - EMEA/V/C/000048 - R/0004
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Pharmacotherapeutic group
Corticosteroids, dermatological preparations
Therapeutic indication
Therapeutic indication
Treatment of acute localised moist dermatitis.